Literature DB >> 27858935

Multiethnic involvement in autosomal-dominant optic atrophy in Singapore.

J L Loo1, S Singhal1,2,3, A V Rukmini3, S Tow1, P Amati-Bonneau4, V Procaccio4, D Bonneau4, J J Gooley3, P Reynier4, M Ferré4, D Milea1,2,3,4.   

Abstract

PurposeAutosomal-dominant optic atrophy (ADOA), often associated with mutations in the OPA1 gene (chromosome 3q28-q29) is rarely reported in Asia. Our aim was to identify and describe this condition in an Asian population in Singapore.Patients and methodsPreliminary cross-sectional study at the Singapore National Eye Centre, including patients with clinical suspicion of ADOA, who subsequently underwent genetic testing by direct sequencing of the OPA1 gene.ResultsAmong 12 patients (10 families) with clinically suspected ADOA, 7 patients (5 families) from 3 different ethnic origins (Chinese, Indian, and Malay) carried a heterozygous pathogenic variant in the OPA1 gene. The OPA1 mutations were located on exons 8, 9, 11, and 17: c.869G>A (p.Arg290Glu), c.892A>G (p.Ser298Gly), c.1140G>A (splicing mutation), and c.1669C>T (p.Arg557*), respectively. One splicing mutation (c.871-1G>A) was identified in intron 8. We also identified a novel mutation causing optic atrophy and deafness (c.892A>G (p.Ser298Gly)). Among the phenotypic features, colour pupillometry disclosed a dissociation between low vision and preserved pupillary light reflex in ADOA.ConclusionWe report the first cases of genetically confirmed OPA1-related ADOA from Singapore, including a novel mutation causing 'ADOA plus' syndrome. Further epidemiological studies are needed in order to determine the prevalence of ADOA in South-East Asia.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27858935      PMCID: PMC5350376          DOI: 10.1038/eye.2016.255

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  35 in total

1.  OPA1 mutations in Japanese patients suspected to have autosomal dominant optic atrophy.

Authors:  Tetsuya Hamahata; Takuro Fujimaki; Keiko Fujiki; Ai Miyazaki; Atsushi Mizota; Akira Murakami
Journal:  Jpn J Ophthalmol       Date:  2011-11-01       Impact factor: 2.447

Review 2.  Dominant optic atrophy.

Authors:  Guy Lenaers; Christian Hamel; Cécile Delettre; Patrizia Amati-Bonneau; Vincent Procaccio; Dominique Bonneau; Pascal Reynier; Dan Milea
Journal:  Orphanet J Rare Dis       Date:  2012-07-09       Impact factor: 4.123

3.  Sensorineural hearing loss in OPA1-linked disorders.

Authors:  Stéphanie Leruez; Dan Milea; Sabine Defoort-Dhellemmes; Estelle Colin; Martine Crochet; Vincent Procaccio; Marc Ferré; Julie Lamblin; Valérie Drouin; Catherine Vincent-Delorme; Guy Lenaers; Christian Hamel; Catherine Blanchet; Gitte Juul; Michael Larsen; Christophe Verny; Pascal Reynier; Patrizia Amati-Bonneau; Dominique Bonneau
Journal:  Brain       Date:  2013-02-04       Impact factor: 13.501

4.  Structural model of the OPA1 GTPase domain may explain the molecular consequences of a novel mutation in a family with autosomal dominant optic atrophy.

Authors:  Sharareh Dadgar; Olivier Hagens; Seyed Razi Dadgar; Ehsan Nobakht Haghighi; Simone Schimpf; Bernd Wissinger; Masoud Garshasbi
Journal:  Exp Eye Res       Date:  2006-05-12       Impact factor: 3.467

5.  Autosomal dominant optic atrophy: penetrance and expressivity in patients with OPA1 mutations.

Authors:  Amy C Cohn; Carmel Toomes; Catherine Potter; Katherine V Towns; Alex W Hewitt; Chris F Inglehearn; Jamie E Craig; David A Mackey
Journal:  Am J Ophthalmol       Date:  2007-02-15       Impact factor: 5.258

6.  Novel mutations of the OPA1 gene in Chinese dominant optic atrophy.

Authors:  May-Yung Yen; An-Guor Wang; Yen-Ching Lin; Ming-Ji Fann; Kwang-Jen Hsiao
Journal:  Ophthalmology       Date:  2009-12-06       Impact factor: 12.079

7.  Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations.

Authors:  Marc Ferré; Dominique Bonneau; Dan Milea; Arnaud Chevrollier; Christophe Verny; Hélène Dollfus; Carmen Ayuso; Sabine Defoort; Catherine Vignal; Xavier Zanlonghi; Jean-Francois Charlin; Josseline Kaplan; Sylvie Odent; Christian P Hamel; Vincent Procaccio; Pascal Reynier; Patrizia Amati-Bonneau
Journal:  Hum Mutat       Date:  2009-07       Impact factor: 4.878

8.  Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega.

Authors:  Fabian Sievers; Andreas Wilm; David Dineen; Toby J Gibson; Kevin Karplus; Weizhong Li; Rodrigo Lopez; Hamish McWilliam; Michael Remmert; Johannes Söding; Julie D Thompson; Desmond G Higgins
Journal:  Mol Syst Biol       Date:  2011-10-11       Impact factor: 11.429

9.  OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes.

Authors:  Patrizia Amati-Bonneau; Maria Lucia Valentino; Pascal Reynier; Maria Esther Gallardo; Belén Bornstein; Anne Boissière; Yolanda Campos; Henry Rivera; Jesús González de la Aleja; Rosanna Carroccia; Luisa Iommarini; Pierre Labauge; Dominique Figarella-Branger; Pascale Marcorelles; Alain Furby; Katell Beauvais; Franck Letournel; Rocco Liguori; Chiara La Morgia; Pasquale Montagna; Maria Liguori; Claudia Zanna; Michela Rugolo; Andrea Cossarizza; Bernd Wissinger; Christophe Verny; Robert Schwarzenbacher; Miguel Angel Martín; Joaquín Arenas; Carmen Ayuso; Rafael Garesse; Guy Lenaers; Dominique Bonneau; Valerio Carelli
Journal:  Brain       Date:  2007-12-24       Impact factor: 13.501

10.  An integrated map of genetic variation from 1,092 human genomes.

Authors:  Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.